Trial NCT03419403

View at ClinicalTrials.gov 
Org. Study IDs: M16-534
Secondary IDs: 2017-003171-64

Last trial update was posted on 2021-04-14

MeSH Interventions

ABT-414 Ophthalmic Solutions Temozolomide Vasoconstrictor Agents

MeSH Conditions

Glioblastoma

Other Conditions

Glioblastoma Multiforme

Stopping Reasons

The study was terminated because clinical development of depatuxizumab mafodotin in glioblastoma was stopped due to lack of survival benefit.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID